mhurhangee/ep-ind-claims huggingface dataset:
An ink composition for inkjet recording comprising: a photopolymerization initiator; an ester or amide of a mono-functional (meth)acrylic acid having an alkylene oxide repeating unit in a molecule which is a compound expressed by the following formula: wherein, in formula, R 1 denotes a hydrogen atom or a methyl group; X denotes an oxygen atom or NR' in which R' denotes a hydrogen atom or an alkyl group; Z 1 and Z 2 each independently denote an alkylene group having 1 to 6 carbon atoms; n is an integer from 3 to 80; m is an integer from 0 to 80; when m is an integer of 1 or more, Z 1 and Z 2 are not the same; and R 2 denotes a hydrogen atom or a mono-valent organic group; (B-2) an ester or amide of a mono-functional (meth)acrylic acid, wherein said ester is an ester between an alkyl alcohol having 6 to 12 carbon atoms and (meth)acrylic acid and said amide is an amide between an amine having an alkyl portion having 6 to 12 carbon atoms and (meth)acrylic acid wherein when two alkyl groups are directly connected to the nitrogen atom of an amide bond, the total sum of carbon atoms contained in the two alkyl groups is 6 to 12; and a colorant; wherein the content of the ester or amide of a mono-functional (meth)acrylic acid having an alkylene oxide repeating unit in a molecule is in the range of 3 to 50 mass percent with respect to a total mass of the ink composition and the content of the (B-2) ester or amide of a mono-functional (meth)acrylic acid having an alkyl portion having 6 to 12 carbon atoms is in the range of 10 to 35 mass percent with respect to a total mass of the ink composition. a photopolymerization initiator; an ester or amide of a mono-functional (meth)acrylic acid having an alkylene oxide repeating unit in a molecule which is a compound expressed by the following formula: wherein, in formula, R 1 denotes a hydrogen atom or a methyl group; X denotes an oxygen atom or NR' in which R' denotes a hydrogen atom or an alkyl group; Z 1 and Z 2 each independently denote an alkylene group having 1 to 6 carbon atoms; n is an integer from 3 to 80; m is an integer from 0 to 80; when m is an integer of 1 or more, Z 1 and Z 2 are not the same; and R 2 denotes a hydrogen atom or a mono-valent organic group; (B-2) an ester or amide of a mono-functional (meth)acrylic acid, wherein said ester is an ester between an alkyl alcohol having 6 to 12 carbon atoms and (meth)acrylic acid and said amide is an amide between an amine having an alkyl portion having 6 to 12 carbon atoms and (meth)acrylic acid wherein when two alkyl groups are directly connected to the nitrogen atom of an amide bond, the total sum of carbon atoms contained in the two alkyl groups is 6 to 12; and (B-2) an ester or amide of a mono-functional (meth)acrylic acid, wherein said ester is an ester between an alkyl alcohol having 6 to 12 carbon atoms and (meth)acrylic acid and said amide is an amide between an amine having an alkyl portion having 6 to 12 carbon atoms and (meth)acrylic acid wherein when two alkyl groups are directly connected to the nitrogen atom of an amide bond, the total sum of carbon atoms contained in the two alkyl groups is 6 to 12; and a colorant;
A method for determining a tyre normal force range (F z,min, F z,max) of a tyre force (F z) acting on a vehicle, the method comprising; obtaining suspension data associated with a suspension system of the vehicle; obtaining inertial measurement unit, IMU, data associated with the vehicle; estimating, by a suspension-based estimator a first tyre normal force range (F z1,min, F z1,max) based on the suspension data; estimating, by an inertial force-based estimator, a second tyre normal force range (F z2,min, F z2,max) based on the IMU data; and determining the tyre normal force range (F z,min, F z,max) based on the first tyre normal force range (F z1,min, F z1,max) and on the second tyre normal force range (F z2,min, F z2,max). obtaining suspension data associated with a suspension system of the vehicle; obtaining inertial measurement unit, IMU, data associated with the vehicle; estimating, by a suspension-based estimator a first tyre normal force range (F z1,min, F z1,max) based on the suspension data; estimating, by an inertial force-based estimator, a second tyre normal force range (F z2,min, F z2,max) based on the IMU data; and determining the tyre normal force range (F z,min, F z,max) based on the first tyre normal force range (F z1,min, F z1,max) and on the second tyre normal force range (F z2,min, F z2,max).
A method of preparing a positive electrode active material, the method comprising: mixing a nickel cobalt manganese hydroxide precursor containing nickel in an amount of 60 mol% or more based on a total number of moles of transition metals, a lithium-containing raw material, and a compound represented by Formula 2 as a doping raw material; and sintering the mixture to prepare a positive electrode active material represented by Formula 1: [Formula 1] Li 1+x [Ni a Me 1-(a+b) M 1 b] 1-x O 2 [Formula 2] Li 1+x1 M 2 O 2+y wherein, in Formula 1, 0≤x≤0.1, 0.6≤a≤0.9995, 0.0005≤b≤0.01, 0.6005≤a+b<1, Me comprises at least two selected from the group consisting of cobalt (Co), manganese (Mn), and aluminum (Al), and M 1 comprises at least one selected from the group consisting of lithium (Li), zirconium (Zr), titanium (Ti), tantalum (Ta), silicon (Si), and niobium (Nb), and wherein, in Formula 2, 0≤x1≤7, 1≤y<6, and M 2 comprises at least one selected from the group consisting of Li, Zr, Ti, Ta, Si, and Nb. mixing a nickel cobalt manganese hydroxide precursor containing nickel in an amount of 60 mol% or more based on a total number of moles of transition metals, a lithium-containing raw material, and a compound represented by Formula 2 as a doping raw material; and sintering the mixture to prepare a positive electrode active material represented by Formula 1: [Formula 1] Li 1+x [Ni a Me 1-(a+b) M 1 b] 1-x O 2 [Formula 2] Li 1+x1 M 2 O 2+y wherein, in Formula 1, 0≤x≤0.1, 0.6≤a≤0.9995, 0.0005≤b≤0.01, 0.6005≤a+b<1, Me comprises at least two selected from the group consisting of cobalt (Co), manganese (Mn), and aluminum (Al), and M 1 comprises at least one selected from the group consisting of lithium (Li), zirconium (Zr), titanium (Ti), tantalum (Ta), silicon (Si), and niobium (Nb), and wherein, in Formula 2, 0≤x1≤7, 1≤y<6, and M 2 comprises at least one selected from the group consisting of Li, Zr, Ti, Ta, Si, and Nb.
A method for operating a combined cycle power plant (CCPP), the method comprising: generating a power plant model for operating the CCPP at an ambient condition and a load condition; determining whether at least two gas turbines (30A, 30B) in the power plant model of the CCPP generate a power output at the ambient condition and the load condition; modeling a fuel consumption of the CCPP for a baseline split ratio between the at least two gas turbines (30A, 30B) using the power plant model of the CCPP at the ambient condition and the load condition; creating a variant split ratio between the at least two gas turbines (30A, 30B); determining, using the power plant model, whether the variant split ratio meets a quality threshold for the CCPP, the quality threshold including at least a minimum reduction in the fuel consumption; recalculating the variant split ratio in response to the variant split ratio not meeting the quality threshold; and adjusting the CCPP to use the variant split ratio in response to the variant split ratio meeting the quality threshold. generating a power plant model for operating the CCPP at an ambient condition and a load condition; determining whether at least two gas turbines (30A, 30B) in the power plant model of the CCPP generate a power output at the ambient condition and the load condition; modeling a fuel consumption of the CCPP for a baseline split ratio between the at least two gas turbines (30A, 30B) using the power plant model of the CCPP at the ambient condition and the load condition; creating a variant split ratio between the at least two gas turbines (30A, 30B); determining, using the power plant model, whether the variant split ratio meets a quality threshold for the CCPP, the quality threshold including at least a minimum reduction in the fuel consumption; recalculating the variant split ratio in response to the variant split ratio not meeting the quality threshold; and adjusting the CCPP to use the variant split ratio in response to the variant split ratio meeting the quality threshold.
Ligand of the receptor B7h for use in treatment of a subject suffering from osteopenia or osteoporosis, wherein the ligand of the receptor B7h have the ability of triggering the receptor B7h activity in osteoclasts wherein the ligand is selected from: a) a human ICOS protein having the amino acid sequence set forth in SEQ ID No.: 29; b) a homologue of human ICOS protein having at least 80%, preferably at least 90% sequence homology to the amino acid sequence set forth in SEQ ID No.: 29; c) a human ICOS portion of the amino acid sequence set forth in SEQ ID No.: 29 having the ability of binding to the receptor B7h and inhibiting osteoclasts differentiation, maturation and/or function; d) a human ICOS extracellular domain having the amino acid sequence set forth in SEQ ID No.: 2; e) a human ICOS extracellular domain portion of the amino acid sequence set forth in SEQ ID No.: 2 having the ability of binding to the receptor B7h and inhibiting osteoclasts differentiation, maturation and/or function of the amino acid sequence set forth in SEQ ID No.: 2; or f) a homologue of human ICOS extracellular domain having at least 80%, preferably at least 90% sequence homology to the amino acid sequence set forth in SEQ ID No.: 2 and having the ability of binding to the receptor B7h and inhibiting osteoclasts differentiation, maturation and/or function of the amino acid sequence set forth in SEQ ID No.: 2. a) a human ICOS protein having the amino acid sequence set forth in SEQ ID No.: 29; b) a homologue of human ICOS protein having at least 80%, preferably at least 90% sequence homology to the amino acid sequence set forth in SEQ ID No.: 29; c) a human ICOS portion of the amino acid sequence set forth in SEQ ID No.: 29 having the ability of binding to the receptor B7h and inhibiting osteoclasts differentiation, maturation and/or function; d) a human ICOS extracellular domain having the amino acid sequence set forth in SEQ ID No.: 2; e) a human ICOS extracellular domain portion of the amino acid sequence set forth in SEQ ID No.: 2 having the ability of binding to the receptor B7h and inhibiting osteoclasts differentiation, maturation and/or function of the amino acid sequence set forth in SEQ ID No.: 2; or f) a homologue of human ICOS extracellular domain having at least 80%, preferably at least 90% sequence homology to the amino acid sequence set forth in SEQ ID No.: 2 and having the ability of binding to the receptor B7h and inhibiting osteoclasts differentiation, maturation and/or function of the amino acid sequence set forth in SEQ ID No.: 2.
A composition comprising self-assembling peptidomimetics, comprising alternating hydrophobic and hydrophilic residues, wherein the hydrophilic residues alternate between positively-charged and negatively- charged residues, wherein the self-assembling peptidomimetics are selected from the group consisting of N, N'-linked oligoureas, oligopyrrolinones, oxazolidin-2-ones, azatides, azapeptides, β-peptides, γ-peptides, δ-peptides, and copolymers of α-peptides, β-peptides, γ-peptides, and δ-peptides, wherein the peptides have a length within the range of 6-64 amino acid residues for use in a method for inhibiting movement of a bodily fluid and/or contaminant on or in an animal when administered to a site in need thereof, wherein the self-assembling peptidomimetics are able, upon interaction with at least one ionic species present in or on an animal, to form a structure that inhibits movement of a bodily fluid and/or contaminant on or in the animal.
Device for mobility rehabilitation comprising a table, hinged at an end to a support structure and respective actuator, configured to make said table rotate between a horizontal position and a vertical position, said table being provided with a harness configured to fasten a patient positioned thereon so that the patient cannot fall down even when the table is in vertical position, said rehabilitation device comprising also a lower limbs movement mechanism configured to make the patient's femur rotate with respect to the hip and a couple of feet movement platforms, characterized in that said device comprises also a plurality of infrared light sources, fastened to respective supports integral to said support structure and positioned so that each light source lights up the muscles of a respective area of the patient's lower limbs, a data processing and control unit configured to control said lower limbs movement mechanism and said light sources, and in that said data processing and control unit is configured also to manage an adjusting cycle of the intensity of said light sources in a differentiated manner for each of said sources, as a function of the movement cycle imposed by said couple of mobilization actuators of the lower limbs. said rehabilitation device comprising also a lower limbs movement mechanism configured to make the patient's femur rotate with respect to the hip and a couple of feet movement platforms, characterized in that said device comprises also a plurality of infrared light sources, fastened to respective supports integral to said support structure and positioned so that each light source lights up the muscles of a respective area of the patient's lower limbs, a data processing and control unit configured to control said lower limbs movement mechanism and said light sources, and in that said data processing and control unit is configured also to manage an adjusting cycle of the intensity of said light sources in a differentiated manner for each of said sources, as a function of the movement cycle imposed by said couple of mobilization actuators of the lower limbs.
A crush box, which has a tubular body having a plurality of flat plate-shape sidewalls and having a polygonal shape in section, which is disposed in such an attitude that an axial direction of the tubular body matches a longitudinal direction of a vehicle, and which, when subjected to a compressive load in the axial direction, is crushed like an accordion in the axial direction to absorb impact energy, wherein a plurality of flanges (48, 50) projecting outward from the tubular body are provided along only a plurality of outer ridges (40, 42) located on an outer side in a lateral direction of the vehicle out of a plurality of ridges located along a boundary between the plurality of sidewalls, such that the plurality of flanges extend along an entire axial length of the tubular body, the tubular body is formed by a pair of body halves (44, 46) divided by a pair of upper and lower outer ridges (40, 42) located at upper and lower positions on the outer side in the lateral direction of the vehicle out of the plurality of ridges located along the boundary between the plurality of sidewalls, each of the pair of body halves has joint portions (48, 50) at its both ends located along the pair of upper and lower outer ridges, the joint portions are placed on each other and bonded together and project outward from the tubular body, and a pair of upper and lower flanges (48, 50) functioning as the plurality of flanges are formed by the joint portions, characterized in that the upper flange has an angle of more than 60° with respect to each of a pair of sidewalls adjoining each other with the upper outer ridge interposed therebetween and is tilted outward in the lateral direction of the vehicle by 15° or more from a vertical line in a vertical direction of the vehicle so that the upper flange projects obliquely upward and outward in the lateral direction of the vehicle in section perpendicular to the axial direction of the tubular body, and the lower flange has an angle of more than 60° with respect to each of a pair of sidewalls adjoining each other with the lower outer ridge interposed therebetween and is tilted outward in the lateral direction of the vehicle by 15° or more from the vertical line in a vertical direction of the vehicle so that the lower flange projects obliquely downward and outward in the lateral direction of the vehicle in section perpendicular to the axial direction of the tubular body.
Hard-boiled egg having a presplit with a predetermined shape (13, 14; 20, 21, 22) on the shell thereof, arranged in such a way as to allow the said shell to be removed more easily, the said hard-boiled egg being packaged with its shell in a packaging.
A measuring device for continuous determination of intra-arterial blood pressure on at least one finger of a hand, which comprises: a base part, a cuff part which is connectable to the base part without tools and separatable from the base part without tools and which comprises at least one ring-like receiving tube for receiving a portion of a finger of a hand passed through the receiving tube, and at least one cuff pad which is arranged in the receiving tube and fillable with a fluid, a radiation source for emitting light into the finger through an optical emission surface, a photodetector for detecting a portion of the light collected by an optical collector surface and not absorbed in the finger, and a pressure control system disposed at least partially in the base part for controlling a fluid pressure in the cuff pad in response to the detected non-absorbed portion of the light, characterized in that the cuff part further comprises a palm rest for supporting the palm of the hand and at least one finger rest associated with each of the at least one receiving tube, respectively, for supporting the portion of the finger protruding beyond the respective receiving tube, and the cuff part projects beyond the base part in the longitudinal direction towards the front and towards the rear, the longitudinal direction being defined as the direction of intended insertion of the finger into the receiving tube or of the fingers into the receiving tubes, the palm rest being arranged behind and the at least one finger rest being arranged in front of the receiving tube. a base part, a cuff part which is connectable to the base part without tools and separatable from the base part without tools and which comprises at least one ring-like receiving tube for receiving a portion of a finger of a hand passed through the receiving tube, and at least one cuff pad which is arranged in the receiving tube and fillable with a fluid, a radiation source for emitting light into the finger through an optical emission surface, a photodetector for detecting a portion of the light collected by an optical collector surface and not absorbed in the finger, and a pressure control system disposed at least partially in the base part for controlling a fluid pressure in the cuff pad in response to the detected non-absorbed portion of the light, characterized in that the cuff part further comprises a palm rest for supporting the palm of the hand and at least one finger rest associated with each of the at least one receiving tube, respectively, for supporting the portion of the finger protruding beyond the respective receiving tube, and the cuff part projects beyond the base part in the longitudinal direction towards the front and towards the rear, the longitudinal direction being defined as the direction of intended insertion of the finger into the receiving tube or of the fingers into the receiving tubes, the palm rest being arranged behind and the at least one finger rest being arranged in front of the receiving tube.
Hip joint implant for fastening to a pelvic bone, with a support body which has a socket and whose convex outer face is designed to bear on the pelvic bone and which, on its concave inner face, has a receiving seat for a pelvis-side bearing that is designed to receive a joint head of a femoral component of a hip prosthesis, and with outwardly directed flat fastening brackets (2, 3) which are arranged at the edge region of the socket, are made of a reshapeable biocompatible material and are each provided with at least one receiving seat for a fastening means, wherein the socket is made of another, stiffer biocompatible material, wherein the fastening brackets (2, 3) are made in one piece with a fastening ring already prefabricated with an opening for receiving the socket and are connected to the socket by a non-releasable cohesive bond, wherein the socket is provided with a preferably circumferential support shoulder in the region where the fastening ring is received, such that the fastening brackets (2, 3) and the fastening ring are supported on the support shoulder.
A transdermally absorbable preparation, of which a base comprises a drug and composite particles, which are composed of at least a silicate compound, an organic acid, and its salt.
A method for sending a Rich Communication Suite, RCS, service message, comprising: reporting, by an RCS client, first information to an RCS system, wherein the first information is used for defining a pushing range of an RCS service message; and sending, by the RCS client, an RCS service message carrying indication information to an RCS Application Server, AS, wherein the indication information is used for indicating to push the RCS service message according to the first information, wherein sending, by the RCS client, the RCS service message carrying the indication information to the RCS AS comprises: sending, by the RCS client in a case of determining that an option of pushing the RCS service message according to the first information has been activated, the RCS service message carrying the indication information. reporting, by an RCS client, first information to an RCS system, wherein the first information is used for defining a pushing range of an RCS service message; and sending, by the RCS client, an RCS service message carrying indication information to an RCS Application Server, AS, wherein the indication information is used for indicating to push the RCS service message according to the first information, wherein sending, by the RCS client, the RCS service message carrying the indication information to the RCS AS comprises: sending, by the RCS client in a case of determining that an option of pushing the RCS service message according to the first information has been activated, the RCS service message carrying the indication information.